Basilea Pharmaceutica AG (SWX: BSLN)

Basilea Pharmaceutica AG Ratios and Metrics

Market cap in millions CHF. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Nov 20, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	489	423	546	485	574	503
Market Cap Growth	-6.69%	-22.52%	12.62%	-15.59%	14.12%	15.74%
Enterprise Value	539	505	636	551	662	523
Last Close Price	40.35	35.30	45.80	40.92	53.15	46.86
PE Ratio	-	41.05	44.90	-	-	-
Forward PE	9.21	15.17	98.35	-	-	-
PS Ratio	3.26	2.68	3.69	3.27	4.50	3.74
PB Ratio	29.14	-42.28	-26.35	-8.27	-5.63	-5.41
P/TBV Ratio	28.90	-	-	-	-	-
P/FCF Ratio	52.39	31.48	139.32	-	-	-
P/OCF Ratio	45.76	29.69	77.36	-	-	-
EV/Sales Ratio	3.61	3.20	4.31	3.72	5.19	3.89
EV/EBITDA Ratio	-	21.78	29.31	154.82	-	-
EV/EBIT Ratio	-	23.05	30.58	183.33	-	-
EV/FCF Ratio	57.69	37.59	162.43	-	-	-
Debt / Equity Ratio	6.70	-12.86	-9.03	-3.74	-2.37	-2.14
Debt / EBITDA Ratio	-	5.05	7.76	41.61	-	-
Debt / FCF Ratio	12.05	9.57	47.76	-	-	-
Asset Turnover	0.71	0.80	0.63	0.62	0.57	0.53
Inventory Turnover	4.38	4.13	4.19	5.33	6.11	7.37
Quick Ratio	2.96	2.48	1.96	1.22	3.87	2.08
Current Ratio	4.10	3.20	2.34	1.38	4.46	2.45
Return on Equity (ROE)	-4.10%	-	-	-	-	-
Return on Assets (ROA)	-2.05%	6.95%	5.56%	0.79%	-5.93%	-3.89%
Return on Capital (ROIC)	-2.73%	9.61%	7.96%	1.25%	-10.88%	-8.30%
Earnings Yield	-0.13%	2.47%	2.23%	-1.41%	-2.56%	-4.46%
FCF Yield	1.91%	3.18%	0.72%	-6.73%	-9.75%	-12.75%
Buyback Yield / Dilution	6.73%	-1.67%	-2.24%	-13.62%	4.41%	0.76%
Total Shareholder Return	6.73%	-1.67%	-2.24%	-13.62%	4.41%	0.76%

Source: S&P Capital IQ. Standard template. Financial Sources.